GENT, BELGIUM -- (Marketwired) -- 08/16/13 -- Remedent, Inc. (OTCBB: REMI), an international company specializing in research, development, and manufacturing of oral care and cosmetic dentistry products, reported results for the first quarter ended June 30, 2013.
Conference Call Information:
Remedent will host a conference call on Tuesday, August 20, 2013 at 11:00 a.m. Eastern Standard Time (8:00 a.m. Pacific Standard Time) to discuss its strategic plans for the future. A question and answer session will follow the presentation.
To participate in this call, dial the appropriate number 5-10 minutes prior to the start time.
Date: Tuesday, August 20, 2013
Time: 11:00 a.m. Eastern Standard Time. (8:00 a.m. Pacific Standard Time)
Dial in Number: 888-500-6950
Password : 7196217
A telephone replay of the call will be available until August 31, 2013
Toll Free Replay Number: 888-203-1112
Replay Password: 7196217
We also like to mention that as of Tuesday, August 20, 2013 an online presentation will be available at our Website www.Remedent.com/investors
Remedent, Inc. specializes in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products. The company serves professional dental industry with breakthrough technology for dental veneers. These products are supported by a line of professional veneer whitening and teeth sensitivity solutions. Headquartered in Belgium, Remedent distributes its products to more than 28 countries worldwide. For more information, go to www.remedent.com.
Statements in this press release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," "projects," "project," to be uncertain and forward-looking. Actual results could differ materially because of factors such as Remedent's ability to achieve the synergies and value creation contemplated by the proposed transaction. For further information regarding risks and uncertainties associated with Remedent's business, please refer to the risk factors described in Remedent's filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. We undertake no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.
For more info, please contact:
Mr Luc Maes
Marketing Manager Remedent
Zuiderlaan 1-3 box 8, 9000 Gent - Belgium
T: +32 (0)9-2415880
Most Popular Stories
- Consumer Prices Edge Up, Surprising Economists
- Do Voters Want Compromise?
- Clinton Rallies New England Women
- Timeline for New York Ebola Doctor
- Market Jolt Offers a Reality Check for Investors
- Stocks Close Out Best Week in Nearly 2 Years
- 'Kissing Congressman' Admits Mistake in Reelection Bid
- Ebola in New York, Mali Raises Travel Jitters
- Microsoft Earnings Drive Stocks Higher
- Steris to Add 100 Jobs in Birmingham